GlassScriptPhysician profile
Robert C Welliver
NPI 1124287651
$3,135.57
in general payments reported to CMS, 2019-2025
16 companies · $659 in 2025
The $659 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $308 · 2020: $14.72 · 2021: $591 · 2022: $196 · 2023: $738 · 2024: $629 · 2025: $659.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,026.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,026.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $1,615.98 | 2019-2025 | Titan |
| Boston Scientific Corporation | $771.07 | 2020-2025 | Ams 700, Lithovue, Ams 800 Artificial Urinary Sphincter |
| Olympus America INC. | $169.88 | 2023-2025 | Itind System |
| Srs Medical Systems, INC. | $119.24 | 2023-2025 | Urocuff, Urocuff-Dc Disposable, Single, Ct3000 Pro Base Unit |
| Cook Medical LLC | $113.85 | 2025 | Litho 150 |
| Endo Pharmaceuticals INC. | $103.42 | 2021-2023 | Xiaflex, Aveed |
| Antares Pharma, INC. | $50.00 | 2023 | Tlando, Xyosted |
| Ferring Pharmaceuticals INC. | $41.35 | 2024 | Adstiladrin |
| Blue Earth Diagnostics | $38.13 | 2019 | |
| Endo USA, INC. | $23.11 | 2024 | Xiaflex, Aveed |
| Rigicon,INC. | $23.06 | 2024 | Rigi10 Malleable Penile Prosthesis |
| Laborie Medical Technologies Corp. | $19.82 | 2025 | Optilume Bph Drug Coated Balloon Catheter |
| Urogen Pharma, INC. | $16.57 | 2024 | |
| Rochester Medical Corporation | $15.70 | 2022 | |
| Provepharm INC. | $14.39 | 2025 | Bludigo |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Welliver listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.